Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Qyuns Therapeutics Co., Ltd. Class H ( (HK:2509) ).
Qyuns Therapeutics Co., Ltd. successfully held its Annual General Meeting (AGM) on June 20, 2025, where all proposed resolutions were unanimously approved. These resolutions included the approval of the board’s report, the annual financial statements, the profit distribution plan, and the engagement of KPMG as the company’s auditor, reflecting strong shareholder support and stable governance.
More about Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company is listed on the Stock Exchange of Hong Kong and focuses on developing and providing therapeutic solutions.
Average Trading Volume: 197,333
Technical Sentiment Signal: Buy
For a thorough assessment of 2509 stock, go to TipRanks’ Stock Analysis page.